Not a good buy right now: short-term technicals improved, but options flow is strongly bearish and fundamentals are deteriorating.
Price (4.48 pre-market) is already near first resistance (R1 4.511), limiting immediate upside for an impatient entry unless it cleanly breaks and holds above ~4.51–4.62.
Heavy insider selling (+256% last month) is a major negative signal; combined with recent losses, it outweighs the modest technical bounce.
Best stance today: avoid new longs; if already holding, reduce/exit into strength near 4.51–4.62.
Technical Analysis
Trend/momentum: MACD histogram is positive (0.0289) and expanding, indicating a developing bullish momentum phase.
RSI (6): 63.7, neutral-to-bullish but not yet overbought; suggests some room, but momentum is getting “late” for a chase entry.
Moving averages: converging MAs suggest the downtrend may be stabilizing, but not a strong confirmed uptrend.
Sentiment: Open Interest P/C at 1.08 is mildly bearish positioning; Volume P/C at 6.51 is extremely bearish for the session flow.
Activity: today’s volume (338) is ~26.3x the 30-day average, signaling unusual options attention.
Positioning: total OI 63,310 and today vs OI avg 30D at 113.61 suggests elevated positioning/engagement.
Volatility: IV30 at 46.04 vs HV 76.61; IV percentile 24.4 / IV rank 15.39 implies options are not expensive versus recent history—bearish flow is not being “priced out.”
Technical Summary
Sell
6
Buy
11
Positive Catalysts
on 2026-02-26 after hours could re-rate the stock if results/guide surprise to the upside.
Neutral/Negative Catalysts
where rallies can fail quickly.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: 439.3M, down -4.72% YoY (continued top-line contraction).
Profitability: Net income -19.14M, down -356.46% YoY; EPS -0.24, down -366.67% YoY (loss-making and worsening).
Margins: gross margin 21.38%, up +1.38% YoY (a bright spot, but not enough to offset losses).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating or price-target change data was provided, so a recent Wall Street trend assessment cannot be confirmed from the dataset.
Practical “pros vs cons” view from the available data: Pros—improving gross margin and tentative technical stabilization; Cons—shrinking revenue, large losses, and strong insider selling/ bearish options flow dominating the tape.
Wall Street analysts forecast BGS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BGS is 4.1 USD with a low forecast of 3 USD and a high forecast of 5 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
Wall Street analysts forecast BGS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BGS is 4.1 USD with a low forecast of 3 USD and a high forecast of 5 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
4 Hold
1 Sell
Hold
Current: 4.950
Low
3
Averages
4.1
High
5
Current: 4.950
Low
3
Averages
4.1
High
5
TD Cowen
Robert Moskow
Sell
downgrade
$4 -> $3
AI Analysis
2025-08-07
Reason
TD Cowen
Robert Moskow
Price Target
$4 -> $3
AI Analysis
2025-08-07
downgrade
Sell
Reason
TD Cowen analyst Robert Moskow lowered the firm's price target on B&G Foods to $3 from $4 and keeps a Sell rating on the shares. The firm notes management described Q2 as in line with internal expectations and lowered guidance for divestitures as opposed to the core business. NULLtheless, the core sales decline of -4.2% and EBITDA decline of -9% reinforced TD Cowen's concerns about structural challenges in the portfolio, the risk of rising refinancing costs, and what looks like overly optimistic guidance for the second half of the year.
Piper Sandler
Neutral
downgrade
$7 -> $5
2025-05-08
Reason
Piper Sandler
Price Target
$7 -> $5
2025-05-08
downgrade
Neutral
Reason
Piper Sandler lowered the firm's price target on B&G Foods to $5 from $7 and keeps a Neutral rating on the shares. The firm says it had feared B&G's outlook might be worse when it published its 10-Q, which gave color on potential "significant" tariff impacts. However, its exposure looks mostly manageable, with any impact skewed to Spices & Seasonings, Piper adds.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BGS